Stoneridge Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stoneridge Investment Partners's LLY Position: Q2 2026 in Review
Stoneridge Investment Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 1,784 shares worth $2.05M. The stake represents 1.34% of the portfolio and ranks #14 among its holdings. This is a return to the name: Stoneridge Investment Partners previously reported a position in LLY as recently as Q3 2021.
Stoneridge Investment Partners first reported a position in LLY in Q2 2016 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Stoneridge Investment Partners held 1,784 shares of Eli Lilly worth $2.05M as of Q2 2026.
- Eli Lilly was a new Stoneridge Investment Partners position in Q2 2026.
- Eli Lilly made up 1.34% of Stoneridge Investment Partners's portfolio in Q2 2026, its #14 holding.
- Stoneridge Investment Partners first reported a position in Eli Lilly in Q2 2016 and has held it in 3 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.